July 06, 2009
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for November 19, 2008 Subscribe to this News Feed  
 

InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego

Download this press release as an Adobe PDF document.

Stem cell culture innovator asks the regenerative medicine community: "Are Your Cells Free?" Learn more about InVitria at TERMIS North America 2008, Dec. 7-10 in San Diego, CA.
There is an urgent need to eliminate risks of using animal components in these applications and that is a perfect fit for Cellastim and Lacromin.

Fort Collins, CO (PRWEB) November 19, 2008 -- Stem cell culture researchers and the regenerative medicine community are meeting at the 2008 North American Tissue Engineering Meeting TERMIS in San Diego on Dec. 7-10. They will have the chance to learn how InVitria's product line can make their cells "Be Free" of animal components by using defined cell culture media supplements, while also receiving a complimentary InVitria "BE FREE" t-shirt.

BE FREE
BE FREE

InVitria's Cellastim Cellastim a recombinant albumin is an animal free and defined cell culture media supplement. Cellastim has been shown to outperform animal derived albumins such as human serum albumin and bovine serum albumin. In addition, InVitria's Lacromin Lacromin a recombinant lactoferrin is an animal free growth factor that improves cell viability in long-term culture.

"We are excited to attend this premier annual event for the tissue engineering community," said Brandy Sargent, InVitria's Sales Manager. "TERMIS is a great venue for InVitria to share its successes, while also learning from an exceptionally talented group of individuals the discoveries, applications and products for stem cell and regenerative medicine."

"Stem cell media and regenerative medicine are exciting applications for the products we have developed," said Dr. Ning Huang, InVitria's VP of Research and Development. "There is an urgent need to eliminate risks of using animal components in these applications and that is a perfect fit for Cellastim and Lacromin."

About InVitria InVitria
InVitria has developed defined and animal free cell culture media components that enhance productivity, safety and time to market for researchers developing regenerative medicine applications. Customers include biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics companies.

To learn more about InVitria's products, please contact us by e-mail or phone.

E-mail: info @ InVitria.com
Phone: 1-800-916-8311

###

Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1DcmFzLUZhbHUtUHJvZi1UaGlyLVNpbmctWmVybw==


See the original story at: http://www.prweb.com/releases/TERMIS/BEFREE/prweb1637864.htm
Other Releases by this Member
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Erik Vogel
InVitria
970-219-3580
Email us Here

BE FREE - InVitria
InVitria's Cellastim can free your cell culture from serum and animal components
Uploaded: Nov 18, 2008
File Name: BEFREETshirt.jpg

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright